General Announcement::APPROVAL OF FIRST CAPSULE SILDENAFIL DRUG FOR TREATMENT OF MALE ERECTILE DYSFUNCTION IN AUSTRALIA
Issuer & Securities
Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No
Announcement Details
Announcement Title
General Announcement
Date &Time of Broadcast
06-Aug-2018 17:49:48
Status
New
Announcement Sub Title
APPROVAL OF FIRST CAPSULE SILDENAFIL DRUG FOR TREATMENT OF MALE ERECTILE DYSFUNCTION IN AUSTRALIA
Announcement Reference
SG180806OTHR8WDR
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.
Attachments
Press Release_iX Biopharma_SILCAP.pdf
Total size =322K
Related Announcements
Related Announcements